Skip to content
+49 3371 6199600info@celltrend.deIm Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Contact
  • German
  • English
topbar - English
Search:
Suche
CellTrend Luckenwalde
Auftragsforschung, Antikörperdiagnostik
CellTrend LuckenwaldeCellTrend Luckenwalde
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS – CFS/ME – SFN – Long Covid
    • Information for patients
  • AT1R-Antibody ELISA
    • Product information
    • Transplantation
    • Systemic sclerosis
    • Literature
  • ELISA
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS – CFS/ME – SFN – Long Covid
    • Information for patients
  • AT1R-Antibody ELISA
    • Product information
    • Transplantation
    • Systemic sclerosis
    • Literature
  • ELISA
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research

Daily Archives: 27. October 2022

You are here:
  1. Home
  2. 2022
  3. October
  4. 27

New study about dysregulated autoantibodies in Post COVID Syndrome published

NewsBy celltrend celltrend27. October 2022

A new study about dysregulated autoantibodies in Post COVID Syndrome (PCS) has been published in Frontiers in Immunologie! Nearly 160 patients were included in the study and divided into four groups. Most PCS patients present a plethora of symptoms without clear evidence of organ dysfunction. The symptom severity of ME/CFS correlates with natural regulatory autoantibody…

+49 3371 6199600 info@celltrend.de Im Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Data protection declaration
  • Imprint
bottombar - English

FacebookInstagram

Go to Top